Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Future Biotech, officially known as Xi'an Future Biotechnology Co., Ltd., is a leading Chinese biotechnology company specializing in the research, development, and industrialization of bioactive substances. The company is a pioneer in the field of recombinant humanized collagen, utilizing synthetic biology and high-density fermentation technologies to produce high-purity collagen for medical and cosmetic applications. Its product portfolio includes medical-grade dressings, skincare formulations, and bioactive raw materials used in regenerative medicine and aesthetic dermatology. Future Biotech operates large-scale GMP-compliant manufacturing facilities and has established itself as a key player in the global recombinant collagen market, competing with other industry leaders in the synthetic biology space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Future Biotechnology Group.